Vcanbio Cell & Gene Engineering Corp Ltd Capital Reinvestment Ratio
Vcanbio Cell & Gene Engineering Corp Ltd capital reinvestment ratio. Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Capital Reinvestment Ratio of 0.13x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥103.70 Million) in capital expenditures (CN¥13.28 Million). Check Vcanbio Cell & Gene Engineering Corp Ltd (600645) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Vcanbio Cell & Gene Engineering Corp Ltd (1999–2025)
Capital reinvestment ratio of Vcanbio Cell & Gene Engineering Corp Ltd from 1999 to 2025. This chart tracks Vcanbio Cell & Gene Engineering Corp Ltd's Capital Reinvestment Ratio across 25 annual periods. Also explore Vcanbio Cell & Gene Engineering Corp Ltd (600645) net asset momentum to track the company's year-over-year net asset growth rate.
Vcanbio Cell & Gene Engineering Corp Ltd Capital Reinvestment Ratio by Year (1999–2025)
Vcanbio Cell & Gene Engineering Corp Ltd capital reinvestment ratio by year from 1999 to 2025. For the full cash flow conversion analysis, see Vcanbio Cell & Gene Engineering Corp Ltd (600645) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥313.63 Million | CN¥49.56 Million | ▼ -33.1% |
| 2024 | 0.24x | CN¥285.19 Million | CN¥67.32 Million | ▼ -20.3% |
| 2023 | 0.30x | CN¥299.02 Million | CN¥88.61 Million | ▼ -21.8% |
| 2022 | 0.38x | CN¥261.89 Million | CN¥99.19 Million | ▼ -4.8% |
| 2021 | 0.40x | CN¥320.96 Million | CN¥127.74 Million | ▲ +6.0% |
| 2020 | 0.38x | CN¥244.35 Million | CN¥91.72 Million | ▼ -26.3% |
| 2019 | 0.51x | CN¥241.49 Million | CN¥122.95 Million | ▼ -48.3% |
| 2018 | 0.99x | CN¥130.08 Million | CN¥128.13 Million | ▼ -16.6% |
| 2017 | 1.18x | CN¥70.27 Million | CN¥83.02 Million | ▼ -37.1% |
| 2016 | 1.88x | CN¥143.67 Million | CN¥269.85 Million | ▼ -88.1% |
| 2015 | 15.74x | CN¥8.17 Million | CN¥128.70 Million | ▲ +5665.4% |
| 2014 | 0.27x | CN¥221.45 Million | CN¥60.47 Million | ▼ -57.1% |
| 2013 | 0.64x | CN¥110.72 Million | CN¥70.43 Million | ▼ -19.4% |
| 2012 | 0.79x | CN¥70.41 Million | CN¥55.56 Million | ▲ +488.4% |
| 2011 | 0.13x | CN¥110.44 Million | CN¥14.81 Million | ▲ +352.1% |
| 2010 | 0.03x | CN¥175.93 Million | CN¥5.22 Million | ▼ -78.6% |
| 2009 | 0.14x | CN¥124.92 Million | CN¥17.32 Million | ▼ -17.0% |
| 2008 | 0.17x | CN¥121.60 Million | CN¥20.32 Million | ▲ +4.1% |
| 2007 | 0.16x | CN¥111.68 Million | CN¥17.92 Million | ▼ -74.4% |
| 2006 | 0.63x | CN¥76.12 Million | CN¥47.67 Million | ▼ -7.8% |
| 2005 | 0.68x | CN¥84.69 Million | CN¥57.55 Million | ▲ +44.2% |
| 2004 | 0.47x | CN¥57.76 Million | CN¥27.23 Million | ▼ -45.5% |
| 2003 | 0.86x | CN¥41.74 Million | CN¥36.08 Million | ▲ +219.3% |
| 2000 | 0.27x | CN¥31.71 Million | CN¥8.58 Million | ▼ -87.2% |
| 1999 | 2.12x | CN¥4.13 Million | CN¥8.76 Million | — |